Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;1808(6):1448-53.
doi: 10.1016/j.bbamem.2010.08.010. Epub 2010 Aug 18.

Secondary structure, dynamics, and architecture of the p7 membrane protein from hepatitis C virus by NMR spectroscopy

Affiliations

Secondary structure, dynamics, and architecture of the p7 membrane protein from hepatitis C virus by NMR spectroscopy

Gabriel A Cook et al. Biochim Biophys Acta. 2011 Jun.

Abstract

P7 is a small membrane protein that is essential for the infectivity of hepatitis C virus. Solution-state NMR experiments on p7 in DHPC micelles, including hydrogen/deuterium exchange, paramagnetic relaxation enhancement and bicelle 'q-titration,' demonstrate that the protein has a range of dynamic properties and distinct structural segments. These data along with residual dipolar couplings yield a secondary structure model of p7. We were able to confirm previous proposals that the protein has two transmembrane segments with a short interhelical loop containing the two basic residues K33 and R35. The 63-amino acid protein has a remarkably complex structure made up of seven identifiable sections, four of which are helical segments with different tilt angles and dynamics. A solid-state NMR two-dimensional separated local field spectrum of p7 aligned in phospholipid bilayers provided the tilt angles of two of these segments. A preliminary structural model of p7 derived from these NMR data is presented.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Two-dimensional 1H-15N HSQC solution-state NMR spectrum of uniformly 15N-labeled HCV p7 in DHPC micelles at pH 4.0 and 50 °C. The spectrum is fully assigned with each of the backbone amides labeled.
Fig. 2
Fig. 2
Assigned strip plots from the three-dimensional HNCA spectrum of p7. The connectivities of neighboring amino acids are shown, demonstrating how the protein resonances were assigned.
Fig. 3
Fig. 3
1H-15N HSQC spectra of uniformly 15N labeled HCV p7. (A) p7 in micelles in H2O. (B) p7 in micelles in D2O. (C) p7 in micelles with Mn2+-EDTA. (D) p7 in isotropic bicelles. The micelle samples contained 125 mM DHPC. For deuterium exchange experiments the sample was prepared in 75% D2O. Mn2+-EDTA at a concentration of 10 mM was added to the sample for PRE experiments. The isotropic bicelle sample contained DMPC and DHPC (q = 0.5).
Fig. 4
Fig. 4
Secondary structure plots of p7 in DHPC micelles. (A) 1H-15N Residual Dipolar Couplings are plotted with the dipolar waves superimposed. (B) Cα chemical shift index values, (C) 1H-15N Heteronuclear NOEs. (D) 1H-15N HSQC intensities. (E) Relative intensity plots for a sample containing 75% D2O (F) PRE data from a sample containing 10 mM Mn2+-EDTA (G) Intensities from an isotropic bicelle sample with q = 0.5 (G). A schematic representation of the seven structural elements of p7 is at the top of the Figure.
Fig. 5
Fig. 5
Two-dimensional solid-state SAMMY spectrum of uniform 15N-labeled p7 in magnetically-aligned 14-O-PC/6-O-PC bilayers (q = 3.2, w/v = 28%). The spectrum was obtained at 42°C at 700 MHz. Simulated PISA wheels of tilt angles 10° and 25° are superimposed on the spectrum.
Fig. 6
Fig. 6
Schematic structural representation of p7 in a phospholipid bilayer. Each of the seven structural segments is shown, with the four helical segments labeled A through D. The dynamic helices, A and C, are differentiated by their diagonal line pattern. The loop containing the two basic residues is shown facing the ER lumen while the N- and C-termini are shown exposed to the cytosol. The helical segments labeled B and D are shown tilted at 25 and 10°, respectively.

Similar articles

Cited by

References

    1. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991;88:2451–5. - PMC - PubMed
    1. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998;339:1485–92. - PubMed
    1. Hadziyannis SJ, Sette H, Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H, Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004;140:346–55. - PubMed
    1. Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C, Swain M, Kleiner DE, Mahaney K, Hoofnagle JH. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995;123:897–903. - PubMed
    1. Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med. 1998;339:1493–9. - PubMed

Publication types

MeSH terms

LinkOut - more resources